The product, called OraQuick HCV self-test, manufactured by OraSure Technologies, is an extension of the pre-qualified, OraQuick® HCV Rapid Antibody Test, which was initially prequalified by WHO ...

Newark, New Castle, USA, May 04, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports estimated the size of the global market for HIV/HBV/HCV test kits in 2022 to be worth US$ 6.35 Billion, and it is ...

The self-test version, specifically designed for use by lay users, provides individuals with a single kit containing the components that are needed to perform the self-test. WHO recommended HCV ...

World Health Organization prequalifies OraQuick HCV self-test for ... pre-qualified, OraQuick HCV Rapid Antibody Test which was initially prequalified by WHO in 2017 for professional use. The ...

WHO prequalified the OraQuick HCV self-test to enhance hepatitis C diagnosis and treatment. Only 36% of 50 million cases are diagnosed, and 20% treated, according to Dr. Meg Doherty. The 2021 ...

The HIV/HBV/HCV test kits market size is projected to be valued at US$ 6,568.3 million in 2023 and is expected to rise to US$ 11,573.9 million by 2033.

As a global leader in ultra-rapid infectious disease diagnostics, bioLytical is working to ensure our test kits are available across the country so that all Australians can know their status ...